Mesothelioma attacks the thin protective lining that covers your lungs, abdomen, or heart, gradually thickening it with cancerous tissue that compresses organs, traps fluid, and spreads along surfaces rather than growing as a single mass. The disease typically appears 20 to 40 years after asbestos exposure, and its effects on the body depend on where it develops and how far it has progressed.
How Asbestos Triggers the Disease
Asbestos fibers are microscopic, durable, and nearly impossible for your body to break down. Once inhaled, some fibers lodge in the lungs while others migrate through the lymphatic system to the pleura, the membrane surrounding the lungs. Because your immune system can’t dissolve or expel these fibers, it mounts an inflammatory response that never fully resolves.
Macrophages, the immune cells that normally clean up debris, swarm the trapped fibers and release reactive oxygen species and inflammatory signaling molecules. These chemical signals damage the DNA of nearby mesothelial cells over years and even decades. The fibers also cause mesothelial cells to release a protein called HMGB1 into surrounding tissue. HMGB1 acts as a danger signal that triggers further inflammation and prompts nearby immune cells to secrete a compound (TNF-alpha) that paradoxically protects damaged cells from dying. This creates a dangerous cycle: cells with broken DNA survive and keep dividing instead of being cleared away, and the chronic inflammation around them fuels their transformation into cancer.
Asbestos doesn’t transform mesothelial cells into cancer directly. It’s this sustained, indirect process of inflammation, DNA damage, and abnormal cell survival that eventually produces a tumor, which is why the latency period between first exposure and diagnosis is typically 20 to 40 years.
What Pleural Mesothelioma Does to the Chest
About 80% of mesothelioma cases start in the pleura. Rather than forming a discrete lump, the cancer spreads as a sheet of thickened tissue across the pleural surface, progressively encasing the lung like a rind. This thickening restricts the lung’s ability to expand, making each breath shallower and more effortful.
Up to 95% of people with pleural mesothelioma develop pleural effusion, a buildup of fluid between the lung and chest wall. Tumors increase the permeability of blood vessels in the area, allowing protein-rich fluid to leak into the pleural space faster than the body can reabsorb it. The accumulating fluid compresses the lung from the outside, compounding the breathing difficulty caused by the thickened pleura itself. Draining this fluid through a needle procedure called thoracentesis provides temporary relief but doesn’t stop the cancer from producing more.
As the disease advances, it can invade the chest wall (present in 43% of cases in one large study) and infiltrate the pericardium, the sac around the heart, in roughly 29% of cases. Pericardial involvement can lead to fluid around the heart, and in severe cases, cardiac tamponade, where pressure from the fluid prevents the heart from filling properly.
How Peritoneal Mesothelioma Affects the Abdomen
When mesothelioma develops in the peritoneum, the lining of the abdominal cavity, it often produces no symptoms until tumors have spread across the abdominal and pelvic surfaces. The cancer coats organs rather than invading them initially, but it disrupts their function through compression and obstruction.
The abdomen normally contains only about 50 to 75 milliliters of fluid. Peritoneal mesothelioma causes roughly 70% of patients to develop malignant ascites, a significant accumulation of fluid driven by tumor-induced vascular leakiness and, less commonly, blocked lymphatic drainage. This fluid buildup causes visible abdominal swelling, pressure on the stomach and intestines, early fullness after eating, and nausea. As tumors grow along the bowel surfaces, they can physically block the intestines, leading to constipation or complete bowel obstruction.
Because its symptoms overlap heavily with common digestive conditions, peritoneal mesothelioma is frequently mistaken for irritable bowel syndrome, Crohn’s disease, gallstones, or even ovarian cancer before the correct diagnosis is made.
The Rarest Form: Pericardial Mesothelioma
Pericardial mesothelioma accounts for a very small fraction of cases and develops directly in the lining around the heart. It can present as constrictive pericarditis (stiffening of the pericardial sac that limits heart movement), pericardial effusion, cardiac tamponade, or heart failure. In some cases, the tumor mass grows large enough to compress major blood vessels, including the superior vena cava and the aortic root. Because these symptoms mimic more common heart conditions, pericardial mesothelioma is often diagnosed late or discovered incidentally.
Whole-Body Effects
Mesothelioma doesn’t stay local forever. In a study analyzing modern patterns of spread, lymph node involvement was found in 65% of cases. The cancer had spread to the opposite lung in 36% of patients and to bones in 20%, with most bone lesions being destructive rather than bone-forming. Liver metastases were the most common organ involvement, accounting for 78% of cases where the cancer reached internal organs. Less frequently, it spread to the adrenal glands, spleen, and kidneys. Brain metastases occurred in about 3% of patients, and roughly 19% developed visible nodules under the skin.
Beyond the direct effects of tumor growth, mesothelioma drives a systemic inflammatory state. The same signaling molecules that fuel the cancer locally circulate through the bloodstream, contributing to fatigue, unexplained weight loss, loss of appetite, night sweats, and low-grade fevers. Many patients experience significant muscle wasting as the body’s metabolism shifts to support the inflammatory process and the growing cancer at the expense of normal tissue.
Why It’s So Often Caught Late
Mesothelioma’s symptoms are notoriously nonspecific. Shortness of breath, chest pain, cough, and fatigue look like dozens of other conditions. Early-stage pleural mesothelioma is commonly misidentified as emphysema, bronchitis, COPD, or pneumonia. At more advanced stages, it’s frequently confused with lung cancer or adenocarcinoma. Peritoneal cases get labeled as IBS, Crohn’s disease, or ovarian cancer. Even on imaging, cancers that have spread to the chest or abdomen from the breast, ovaries, or digestive tract can look nearly identical to mesothelioma.
The long latency period adds another layer of difficulty. By the time symptoms appear, decades may have passed since asbestos exposure, and patients may not connect the two. The five-year survival rate for pleural mesothelioma ranges from 7% to 24% depending on the stage at diagnosis, and the average survival with treatment is about a year and a half from diagnosis. Earlier detection generally means more treatment options and better outcomes, but the disease’s slow, silent development and mimicry of common illnesses make early diagnosis the exception rather than the rule.